DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
2005 ◽
Vol 352
(26)
◽
pp. 2673-2681
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2006 ◽
Vol 131
(6)
◽
pp. 1743-1751
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 560
◽
pp. 27-34
◽
Keyword(s):
Keyword(s):